| Astrazeneca Pharma India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506820 |
NSE Symbol : ASTRAZEN |
P/E(TTM) : 99.62 |
|
ISIN Demat : INE203A01020 |
Div & Yield% : 0.35 |
EPS(TTM) : 92.47 |
|
Book Value(₹) : 319.60 |
Market Cap(₹Cr) : 23,028.75 |
Face Value(₹) : 2.00 |
| Company Background | |
|---|---|
| Incorporation Year | 1979 |
| Registered Office | Blk N1 12th Flr Manyata Embass Bangalore Karnataka 560045 |
| Telephone | 91-080-67748000 |
| Fax | 91-080-67748557 |
| Chairman | Shilpa Divekar Nirula |
| Managing Director | Praveen Rao Akkinepally |
| Company Secretary | |
| Auditor | Price Waterhouse & Co Chartered Accountants LLP |
| Face Value | 2.0 |
| Market Lot | 1 |
| Listing |
BSE
MSEI
NSE
|
| Registrar | Integrated Enterprises (I) Ltd No. 30 Ramana Resid.,4th Cross Sampige Rd,Malleswaram,Bangalore - 560003 |